Aneurysm Clinical Trial
Official title:
A Clinical Study of Aneurysm Exclusion Using Endologix, Inc. Endoluminal Technology
The ultimate purpose is to explore potential techniques to exclude aneurysms and provide alternative conduit for arterial flow. The single center sponsorship is intended to provide the investigators the potential to incorporate improvements in existing technology during the course of the study thereby ultimately enhancing the potential for superior medical care of patients suffering from these disease states.
The primary objective of this study is to examine the feasibility of expanded applications
of the basic Endologix technology for the treatment of arterial aneurysmal disease. A second
objective of this study is to gather data in order to make logical, scientific
recommendations for device design, construction and application which will expand the
application of the endoluminal graft technology and improve its safety and efficacy while
expanding the several potential future positive aspects of a less invasive method of
treating arterial occlusive disease.
Endologix, Inc. has applied for and received an IDE for the investigation of a bifurcated
device to exclude aneurysms of the abdominal aorta. The Arizona Heart Institute experience
indicates that this small study design will prove successful. Using the basic technology of
the current approved IDE, it is Arizona Heart Institute's intention to expand the scope of
application and design in order to address a greater population basis suffering from
aneurysmal disease. In this regard, the basic Endologix device designs will be applied to
appropriate patients beyond the scope of the current bifurcated IDE. Patients meeting the
criteria for the Endologix IDE will be enrolled independently in that study and followed
precisely in order to comply with the study design. Patients with aneurysmal disease not
currently filling the criteria for a bifurcated abdominal aortic prosthetic but who could
potentially benefit from the technology to exclude aneurysmal disease will be considered
from this study.
The patient's participation in the Study will include enrollment, Investigational Device
procedure and follow-up period. Patient data will be collected for 1, 6, and 12 months and
beyond as indicated. Subject follow-up at 1 month will include; ABIs, a complete Physical
Examination, Duplex Ultrasound, and X-ray. Subject follow-up at 6 and 12 months will also
include ABIs, a complete Physical Examination, CT Scan-Contrast Enhanced (unless
contraindicated), CT Scan-No Contrast, and X-ray.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06235619 -
Arch Size Study for Anatomical Variations
|
||
Not yet recruiting |
NCT00905931 -
Lycopene Following Aneurysmal Subarachnoid Haemorrhage
|
Phase 2 | |
Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A | |
Completed |
NCT00349908 -
A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries
|
Phase 1 | |
Recruiting |
NCT03285100 -
The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation
|
N/A | |
Recruiting |
NCT06189950 -
Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE
|
N/A | |
Active, not recruiting |
NCT04592185 -
The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms
|
||
Completed |
NCT01970605 -
Silver Graft All Comers Registry
|
||
Completed |
NCT00282893 -
Balloon Prophylaxis of Aneurysmal Vasospasm
|
Phase 2 | |
Completed |
NCT04598802 -
COvera in BRAnch Registry
|
||
Completed |
NCT04246125 -
Patient Skin Dose in Interventional Radiology
|
||
Recruiting |
NCT05829746 -
PROSPECTIVE, MULTI-CENTER, OPEN-LABEL, SINGLE-ARM REGISTRATION TRIAL OF THE TUBRIDGE FOR THE TREATMENT OF WIDE-NECKED SMALL AND MEDIUM-SIZED INTRACRANIAL ANEURYSMS
|
N/A | |
Completed |
NCT03242343 -
VasQ External Support for Arteriovenous Fistula
|
N/A | |
Recruiting |
NCT02878967 -
Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain Aneurysm
|
||
Active, not recruiting |
NCT02345005 -
Iliac Branch Excluder ReGistry (IceBERG)
|
||
Recruiting |
NCT02167997 -
EffectiveNess and SAfety of Small ANeurysm COiling Trial
|
N/A | |
Recruiting |
NCT00549016 -
Clinical Study of Aneurysm Exclusion
|
N/A | |
Completed |
NCT02848612 -
Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol
|
||
Enrolling by invitation |
NCT04269447 -
Prospective Aortic Biobank of POP-STAR
|
||
Recruiting |
NCT03496415 -
The Neuroprotective Effect of Remote Ischemic Conditioning in Aneurysm Coiling Therapy
|
Phase 2/Phase 3 |